SCTelcom Transforms Rural Broadband Experiences by Leveraging Calix SmartLife Managed Services for Home, School, and Around Town
SCTelcom continues a 70-year history of supporting their communities by leveraging the Calix broadband platform and SmartLife managed services to expand their business... Read more.
Best’s Review Discusses the AI Revolution
OLDWICK, N.J.–(BUSINESS WIRE)–The November issue of Best’s Review features a joint effort with AM Best TV to explore how artificial intelligence (AI)... Read more.
Generational Equity Advises NewFoundry in its Acquisition by Symphonize
DALLAS–(BUSINESS WIRE)–Generational Equity, a leading mergers and acquisitions advisor for privately held businesses, is pleased to announce that its... Read more.
China Pharmaceutical Competitive Landscape and Drugs Pipeline Analysis Report 2023: Business Overview of 330 Companies, 1500 Drugs in Trials, & 200 Commercially Approved Drugs – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “China Pharmaceutical Companies and Drugs Pipeline Insight 2023” drug pipelines has been added to ResearchAndMarkets.com’s... Read more.
KBRA Releases Monthly CMBS Trend Watch
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases the October 2023 issue of CMBS Trend Watch. The Federal Reserve kept interest rates unchanged at its... Read more.
Africa Investment Forum Schedule Announced: African Heads of State and Industry Leaders to Convene in Marrakech
ABIDJAN, Côte d’Ivoire & MARRAKECH, Morocco–(BUSINESS WIRE)–The Africa Investment Forum (AIF) is set to take place from November 8 to 10 in Marrakech,... Read more.
China Bispecific Antibodies Market and Clinical Pipeline Insight Report 2023: A $5 Billion Opportunity by 2028, 250 Pipeline Bispecific Antibodies, 50 Bispecific Antibodies Available for License – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “China Bispecific Antibodies Market and Clinical Pipeline Insight 2028” drug pipelines has been added to ResearchAndMarkets.com’s... Read more.
Ankyra Therapeutics Announces Promising Preclinical Data on ANK-101, a Novel Anchored Immune Medicine, in Combination with Cytotoxic Chemotherapy in Head and Neck Cancer Model
First-in-class anchored IL-12 immunotherapy mANK-101 shows tumor growth delay in murine models as a monotherapy and in combination with platinum and anti-PD-1 Data... Read more.
Tempus Announces New ctDNA Assay, xF Monitor
Tumor uninformed treatment response monitoring assay for research use only CHICAGO–(BUSINESS WIRE)–Tempus, a leader in artificial intelligence and precision... Read more.
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against UiPath Inc. (PATH)
LOS ANGELES–(BUSINESS WIRE)–The Law Offices of Frank R. Cruz reminds investors of the upcoming November 6, 2023 deadline to file a lead plaintiff motion... Read more.